The use of lisuride in the treatment of multiple system atrophy with autonomic failure (Shy-Drager syndrome).
In a controlled trial lisuride, an ergolene derivative with dopamine receptor agonist properties was given maximum tolerated doses (2.4 mg/day) to seven patients with multiple system atrophy with autonomic failure (Shy-Drager syndrome). Improvement in Parkinsonian features occurred in only one patie...
Na minha lista:
| Publicado no: | J Neurol Neurosurg Psychiatry |
|---|---|
| Principais autores: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
1981
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC490960/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7241162/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/jnnp.44.4.347 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|